Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Systematic Review

Review

Clinical Trial

Comparative Study

Meta-Analysis

Observational Study

Publication Year

From

Quick links

Individual year

2023

2020

2019

2015

2012

2011

2007

2004

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Elephantiasis, Filarial""[mesh_terms]

13 Results

Searching titles within these results

Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host's Immune System.

Puvvada Kalpana Murthy

Current topics in medicinal chemistry 2019;19(14):1226-1240

Full Text

Abstract

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

Eric Kanza, Christopher L King, Bettina Dubben, Augustine R Hong, Achim Hoerauf, Michael E Gyasi, Charles W Goss, Shelter Gordor, Peter U Fischer, Kerstin Fischer, Nicole Fetcho, Felix Doe, Nicholas O Opoku, Ruth Laryea, Daphne Lew, Mahmood A Seidu, Gary J Weil

PLoS neglected tropical diseases 2023;17(5):e0011365

Free Full Text

Abstract

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.

Christabel Khaemba, Abbie Barry, Wyckliff P Omondi, Elvis Kirui, Margaret Oluka, Gurumurthy Parthasarathi, Sammy M Njenga, Anastacia Guantai, Eleni Aklillu

Drug safety 2023;46(10):961-974

Free Full Text

Abstract

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.

Teshome Gebre, David C W Mabey, Michael Marks, Scott McPherson, Hiwot Solomon, Anthony W Solomon, Fikre Seife

PLoS neglected tropical diseases 2023;17(6):e0011224

Free Full Text

Abstract

Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.

Traye Serge, Aboulaye Meite, Jonah Kupritz, Bruce A Rosa, Britt J Andersen, Marla I Hertz, Gary J Weil, Peter U Fischer, Makedonka Mitreva, Christopher L King, Kurt Curtis

PLoS neglected tropical diseases 2020;13(9):e0007697

Free Full Text

Abstract

Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.

Patrick J Lammie, Michael J Beach, Zuzana Kucerova, Alexis Boyd, Tiffany Weinkopff, Jeffrey W Priest, Delynn M Moss

The American journal of tropical medicine and hygiene 2011;85(2):229-37

Free Full Text

Abstract

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.

Cara L Macfarlane, Shyam S Budhathoki, Samuel Johnson, Marty Richardson, Paul Garner

The Cochrane database of systematic reviews 2019;1(1):CD003753

Free Full Text

Abstract

Reporting an alliance using an integrative approach to the management of lymphedema in India.

Saravu R Narahari, Terence J Ryan

The international journal of lower extremity wounds 2012;11(1):5-9

Full Text

Abstract

Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.

Nina O Nielsen, Paul E Simonsen, Peter Dalgaard, Henrik Krarup, Pascal Magnussen, Stephen Magesa, Henrik Friis

The American journal of tropical medicine and hygiene 2007;77(3):507-13

Full Text

Abstract

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole.

R K Shenoy, T K Suma, A John, S R Arun, V Kumaraswami, L L Fleckenstein, K Na-Bangchang

Annals of tropical medicine and parasitology 2002;96(6):603-14

Full Text

Abstract

Oral drug therapy for multiple neglected tropical diseases: a systematic review.

Madhuri Reddy, Sudeep S Gill, Sunila R Kalkar, Wei Wu, Peter J Anderson, Paula A Rochon

JAMA 2007;298(16):1911-24

Full Text

Abstract

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.

N A Kshirsagar, N J Gogtay, B S Garg, P R Deshmukh, D D Rajgor, V S Kadam, B G Kirodian, N S Ingole, A M Mehendale, L Fleckenstein, J Karbwang, J K Lazdins-Helds

Transactions of the Royal Society of Tropical Medicine and Hygiene 2004;98(4):205-17

Full Text

Abstract

Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.

Gopalan R Babu, Bontha V Babu

Transactions of the Royal Society of Tropical Medicine and Hygiene 2015;108(9):538-49

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Elephantiasis, Filarial""[mesh_terms]

Strategies to Control Human Lymphatic Filarial Infection: Tweaking Host's Immune System.

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.

Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.

Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.

Reporting an alliance using an integrative approach to the management of lymphedema in India.

Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole.

Oral drug therapy for multiple neglected tropical diseases: a systematic review.

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.

Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.

Results for
""Elephantiasis, Filarial""[mesh_terms]